
CDT · NASDAQ
CDT Equity Inc.
$0.07 -0.01 (-6.79%)
Company overview
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 and is headquartered in Naples, FL.
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Market cap
- $78,716
- Employees
- 6
- Headquarters
- Naples, FL
- Website
- conduitpharma.com
- CEO
- Andrew Regan
- Listed
- March 28, 2022
- P/E
- -0.00
- Dividend yield
- 0.00%
Company financials
- Revenue
- $696M
- Gross profit
- $258M
- Operating income
- $44.8M
- EBITDA
- $80.2M
- Net income
- $16.6M
- EPS
- -$343.01
- Total assets
- $3.5B
- Total debt
- $1.4B
- Gross margin
- 37.06%
- Net margin
- 2.38%
- Earnings yield
- -490,014.29%
Showing FY 2024